So I think thats the major message as far as Im concerned
GE2 treatment reduced inflammation in the dorsal and ventral hippocampus, however only in SD subjects, regardless of sex, as well as in the amygdala in males regardless of diet
The reverse switch is identical in mechanics
Wegovy and Ozempic are both GLP-1 receptor agonists that contain the same active ingredient, semaglutide, but they are prescribed for different purposes
If chronic pain requires ongoing medication, COX-2 selective inhibitors (like celecoxib) carry lower gastrointestinal risk than traditional NSAIDs, though they still warrant clinical oversight when combined with semaglutide
And there are so many different formulations and combinations out there, and theyre not evaluated by the FDA, just to note that